Trump Seeks to Lower Drug Prices Through Medicare and Some Imports
President Trump directed his administration to help states import drugs from Canada. But a proposal to alter a Medicare program to reduce costs could wind up raising prices.
Regulation and Deregulation of Industry
Trump and DOGE Are Planning Deregulation at a Massive Scale
The White House will soon move to rapidly repeal or freeze rules that affect health, food, workplace safety, transportation and more.
RFK Jr. Accuses FDA of Drug Industry Influence That Barred Alternative Remedies
The nation’s health secretary addressed agency employees, asking them to shed any corporate influence. But he did not address the mass layoffs that have gutted oversight of tobacco and vapes, food safety and drug reviews.
Trump Administration Delays Plan to Limit Pricey Bandages
Medicare spending on “skin substitutes” reached $10 billion last year. A leading seller made a large donation to President Trump’s election campaign.
Medicare Bleeds Billions on Pricey Bandages, and Doctors Get a Cut
Medicare spending on “skin substitutes” made of dried placenta has soared as doctors pocket lucrative discounts from sellers.
Trump Repeals Biden-Era Limit on Water Flow in Shower Heads
President Trump, who signed an executive order about the definition of “shower head” has had a long-running crusade against low water pressure.
Justice Dept. Disbands Cryptocurrency Enforcement Unit
The Trump administration is dialing back its enforcement of cryptocurrency, and criticizing Biden-era prosecutions.
Trump Aides Defend His Tariffs Amid Global Blowback
The president’s top advisers acknowledged President Trump’s sweeping tariffs could raise prices but said an economic adjustment that would ultimately benefit American workers was overdue.
Small Businesses Face a ‘Tornado’ of Challenges: Cuts, Freezes and Now Tariffs
President Trump vowed to aid entrepreneurs by reducing taxes and slicing red tape. But some owners say other policies have put them at a disadvantage.
Trump Rejects Proposal for Medicare to Cover Wegovy and Other Obesity Drugs
Administration officials reversed a decision made during the Biden presidency that would have given millions of people access to weight-loss drugs paid for Medicare and Medicaid.